Octavia Bane1,2, Steven Peti1, Mathilde Wagner2,3, Stefanie Hectors1,2, Hadrien Dyvorne2,4, Michael Markl5,6, Bachir Taouli1,2. 1. Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 2. Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 3. Department of Radiology, Groupe Hospitalier Pitié Salpêtrière, Paris, France. 4. Catalyzer, Guilford, Connecticut, USA. 5. Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 6. Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA.
Abstract
BACKGROUND: The test-retest/interobserver repeatability and diagnostic value of 4D flow MRI in liver disease is underreported. PURPOSE: To determine the reproducibility/repeatability of flow quantification in abdominal vessels using a spiral 4D flow MRI sequence; to assess the value of 4D flow parameters in diagnosing cirrhosis and degree of portal hypertension. STUDY TYPE: Prospective. SUBJECTS: Fifty-two patients with chronic liver disease. FIELD STRENGTH/SEQUENCE: 1.5T/spiral 4D flow acquired in one breath-hold. ASSESSMENT: Thirteen abdominal vessels were identified and segmented by two independent observers to measure maximum and time-averaged through-plane velocity, net flow, and vessel cross-section area. Interobserver agreement and test-retest repeatability were evaluated in 15 and 4 cases, respectively. Prediction of the presence and severity of cirrhosis and portal hypertension was assessed using 4D flow parameters. STATISTICAL TESTS: Cohen's kappa coefficient, coefficient of variation (CV), Bland-Altman, Mann-Whitney tests, logistic regression. RESULTS: For all vessels combined, measurements showed acceptable agreement between observers, with Cohen's kappa = 0.70 (P < 0.001), CV < 21%, Bland-Altman bias <5%, but high limits of agreement ([-75%,75%]). Test-retest repeatability was excellent in large vessels (CV = 1-15%, bias = 1-25%, Bland-Altman limits of agreement [BALA] = [4%,150%]), and poor in small vessels (CV = 7-130%, bias = 10-200%, BALA = [8%,190%]). Average velocity in the right hepatic vein and average area of the splenic vein were higher in cirrhosis (P = 0.027/0.0039). Flow in the middle hepatic vein strongly correlated with Child-Pugh score (ρ = 0.84, P = 0.0238), while flow in the splenic vein (ρ = 0.43, P = 0.032), time-average (ρ = 0.46, P = 0.02) and peak velocity in the superior mesenteric vein (ρ = 0.45, P = 0.032), and peak velocity in the infrarenal IVC (ρ = 0.39, P = 0.032) positively correlated with an imaging-based portal hypertension score. Average area of the splenic vein predicted cirrhosis (P = 0.019; area under the curve AUC [95% confidence interval, CI] = 0.87 [0.71,1.00]) and clinically significant portal hypertension (P = 0.042; AUC [95% CI] = 0.78 [0.57-0.99]). DATA CONCLUSION: Spiral 4D flow allows comprehensive assessment of abdominal vessels in one breath-hold, with substantial interobserver reproducibility, but variable test-retest repeatability. 4D flow may potentially reflect vascular changes due to cirrhosis and portal hypertension. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:994-1005.
BACKGROUND: The test-retest/interobserver repeatability and diagnostic value of 4D flow MRI in liver disease is underreported. PURPOSE: To determine the reproducibility/repeatability of flow quantification in abdominal vessels using a spiral 4D flow MRI sequence; to assess the value of 4D flow parameters in diagnosing cirrhosis and degree of portal hypertension. STUDY TYPE: Prospective. SUBJECTS: Fifty-two patients with chronic liver disease. FIELD STRENGTH/SEQUENCE: 1.5T/spiral 4D flow acquired in one breath-hold. ASSESSMENT: Thirteen abdominal vessels were identified and segmented by two independent observers to measure maximum and time-averaged through-plane velocity, net flow, and vessel cross-section area. Interobserver agreement and test-retest repeatability were evaluated in 15 and 4 cases, respectively. Prediction of the presence and severity of cirrhosis and portal hypertension was assessed using 4D flow parameters. STATISTICAL TESTS: Cohen's kappa coefficient, coefficient of variation (CV), Bland-Altman, Mann-Whitney tests, logistic regression. RESULTS: For all vessels combined, measurements showed acceptable agreement between observers, with Cohen's kappa = 0.70 (P < 0.001), CV < 21%, Bland-Altman bias <5%, but high limits of agreement ([-75%,75%]). Test-retest repeatability was excellent in large vessels (CV = 1-15%, bias = 1-25%, Bland-Altman limits of agreement [BALA] = [4%,150%]), and poor in small vessels (CV = 7-130%, bias = 10-200%, BALA = [8%,190%]). Average velocity in the right hepatic vein and average area of the splenic vein were higher in cirrhosis (P = 0.027/0.0039). Flow in the middle hepatic vein strongly correlated with Child-Pugh score (ρ = 0.84, P = 0.0238), while flow in the splenic vein (ρ = 0.43, P = 0.032), time-average (ρ = 0.46, P = 0.02) and peak velocity in the superior mesenteric vein (ρ = 0.45, P = 0.032), and peak velocity in the infrarenal IVC (ρ = 0.39, P = 0.032) positively correlated with an imaging-based portal hypertension score. Average area of the splenic vein predicted cirrhosis (P = 0.019; area under the curve AUC [95% confidence interval, CI] = 0.87 [0.71,1.00]) and clinically significant portal hypertension (P = 0.042; AUC [95% CI] = 0.78 [0.57-0.99]). DATA CONCLUSION: Spiral 4D flow allows comprehensive assessment of abdominal vessels in one breath-hold, with substantial interobserver reproducibility, but variable test-retest repeatability. 4D flow may potentially reflect vascular changes due to cirrhosis and portal hypertension. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:994-1005.
Authors: Zoran Stankovic; Alex Frydrychowicz; Zoltan Csatari; Elisabeth Panther; Peter Deibert; Wulf Euringer; Wolfgang Kreisel; Maximilian Russe; Simon Bauer; Mathias Langer; Michael Markl Journal: J Magn Reson Imaging Date: 2010-08 Impact factor: 4.813
Authors: Shingo Kihira; Alexander C Kagen; Prasanna Vasudevan; Guido H Jajamovich; Thomas D Schiano; Anne-Fleur Andrle; James S Babb; Aaron Fischman; Bachir Taouli Journal: Abdom Radiol (NY) Date: 2016-01
Authors: Alejandro Roldán-Alzate; Alex Frydrychowicz; Eric Niespodzany; Ben R Landgraf; Kevin M Johnson; Oliver Wieben; Scott B Reeder Journal: J Magn Reson Imaging Date: 2012-11-12 Impact factor: 4.813
Authors: A Frydrychowicz; A Roldan-Alzate; E Winslow; D Consigny; C A Campo; U Motosugi; K M Johnson; O Wieben; S B Reeder Journal: Eur Radiol Date: 2017-06-27 Impact factor: 5.315
Authors: Naaventhan Palaniyappan; Eleanor Cox; Christopher Bradley; Robert Scott; Andrew Austin; Richard O'Neill; Greg Ramjas; Simon Travis; Hilary White; Rajeev Singh; Peter Thurley; Indra Neil Guha; Susan Francis; Guruprasad Padur Aithal Journal: J Hepatol Date: 2016-07-27 Impact factor: 25.083
Authors: Sophie Restellini; Nicolas Goossens; Sophie Clément; Nicolas Lanthier; Francesco Negro; Laura Rubbia-Brandt; Laurent Spahr Journal: World J Hepatol Date: 2018-01-27
Authors: Thekla H Oechtering; Grant S Roberts; Nikolaos Panagiotopoulos; Oliver Wieben; Alejandro Roldán-Alzate; Scott B Reeder Journal: Abdom Radiol (NY) Date: 2021-11-27
Authors: Ryan L Brunsing; Dustin Brown; Hashem Almahoud; Yuko Kono; Rohit Loomba; Irene Vodkin; Claude B Sirlin; Marcus T Alley; Shreyas S Vasanawala; Albert Hsiao Journal: J Magn Reson Imaging Date: 2021-02-16 Impact factor: 5.119